Cosmos Health shareholders approved Series B preferred stock designation at annual meeting
COSM•Annual meeting approvals
Cosmos Health held its annual shareholder meeting on July 15, 2026.
Shareholders ratified the appointment of the company’s independent registered public accounting firm.
Shareholders adopted the 2026 Equity Omnibus Plan.
Shareholders authorized the designation and issuance of 100,000 shares of Series B Preferred Stock; a certificate of designation is expected to be filed.
